IGF-1 and IGFBP-3 in the Athlete Clinical Workup: Why the Spot IGF-1 Alone Misses the Hepatic GH-Resistance Signature of Low Energy Availability, the Computed Molar Ratio That Reads the Ternary-Complex Biology, the Four Paired-Draw Patterns That Classify the GH-IGF-1 Axis, and the SOAP Structure That Carries the Finding Into the Energy-Availability, Training-Load, and Sports-Endocrinology-Referral Branches of the Plan
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a 1.2-kilogram loss of DXA-measured fat-free mass, a luteal-phase deficiency on a four-month basal-body-temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750-kcal need, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as within the age-decade reference bracket and the ordering physician's chart note reads IGF-1 normal, no further endocrine workup indicated. The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool, insulin-like growth factor binding protein 3 (IGFBP-3), and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel. This is the paired IGF-1 plus IGFBP-3 interpretation guide for the sports RD: the GH-receptor-to-JAK2-STAT5 biology that drives the dissociated storage-versus-synthesis signal, the age-decade reference brackets, the four paired-draw patterns that classify the GH-IGF-1 axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the free-T3-and-gonadal-axis RED-S differential, the SOAP structure that carries the finding into the energy-availability, training-load, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a loss of 1.2 kilograms of DXA-measured fat-free mass against stable reported intake, a luteal-phase deficiency on a four-month basal body temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750 kcal need at her current training volume, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as "within the age-decade reference bracket" and the ordering physician's chart note reads "IGF-1 normal, no further endocrine workup indicated." The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 value alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool — insulin-like growth factor binding protein 3, IGFBP-3 — and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel.
The Biology — Why the Molar Ratio Reads What the Spot IGF-1 Cannot
IGF-1 is a 70-amino-acid peptide hormone produced primarily by the hepatocyte under growth-hormone stimulation transduced through the JAK2-STAT5 signaling axis at the hepatic GH receptor. More than 98 percent of circulating IGF-1 is bound in ternary complex with insulin-like growth factor binding protein 3 (IGFBP-3) and the acid-labile subunit (ALS), a 150-kDa complex that extends the IGF-1 plasma half-life from approximately 10 minutes in the free fraction to 12 to 15 hours in the bound fraction. IGFBP-3 accounts for approximately 75 percent of the total IGF-binding-protein pool and is the dominant stoichiometric carrier.
Energy availability and the GH-IGF-1 axis are coupled. Chronic low energy availability — the physiology at the core of the Relative Energy Deficiency in Sport (RED-S) syndrome — reduces hepatic IGF-1 output through two sequential mechanisms. First, a direct GH-resistance pattern develops at the hepatocyte: the GH receptor and the downstream JAK2-STAT5 signaling cascade down-regulate against sustained caloric restriction, so even when pituitary GH secretion rises (the compensatory pulsatile-GH-elevation pattern the LEA literature documents), the hepatic IGF-1 transcriptional response falls. Second, hepatic ALS and IGFBP-3 synthesis fall more slowly than IGF-1 synthesis, so the circulating IGFBP-3 pool shrinks less than the IGF-1 pool shrinks across the same caloric-restriction window.
The clinical consequence is a disproportionate fall in IGF-1 relative to IGFBP-3. The molar ratio — conventionally computed as (IGF-1 in ng/mL) divided by (IGFBP-3 in μg/mL) — drops from its well-fueled reference band of approximately 10-to-16 down toward 6-to-9 across a sustained LEA exposure. The absolute IGF-1 value may still read inside the laboratory-reported reference bracket for the athlete's age decade, but the ratio reads outside the physiologic band that reflects a balanced hepatic GH-IGF-1 axis. The spot IGF-1 alone does not read the discordance; the paired IGF-1/IGFBP-3 draw does.
Reference Brackets by Age Decade
Both markers are strongly age-dependent. IGF-1 peaks during puberty and declines monotonically across each subsequent decade. IGFBP-3 follows a parallel but less steep decline. The laboratory reference bracket is reported as age-decade-stratified, and the sports RD reads the number against the decade on the laboratory report, not a universal adult range.
Approximate adult reference brackets (laboratory-dependent; verify against the issuing lab):
IGF-1 (serum, ng/mL):
- 18–24 years: 180–500
- 25–39 years: 120–380
- 40–54 years: 90–280
- 55+ years: 80–230
IGFBP-3 (serum, μg/mL):
- 18–24 years: 3.5–7.0
- 25–39 years: 3.3–6.7
- 40–54 years: 3.0–6.5
- 55+ years: 2.8–6.3
Computed IGF-1/IGFBP-3 molar ratio reference bracket:
- Balanced hepatic axis: 10–16
- Low-energy-availability discordance: 6–9
- Acute pan-suppression or hepatic failure: below 6
- Elevated-GH-signal pattern (acromegaly, exogenous GH or IGF-1 use, adolescent growth spurt): above 20
Record the percent-of-bracket-midpoint for each raw value in the SOAP Objective section alongside the computed ratio, not just the absolute numbers.
The Four Paired-Draw Patterns
Pattern 1 — Mid-bracket IGF-1, mid-bracket IGFBP-3, ratio inside 10–16. The picture of a well-fueled athlete with an intact hepatic GH-IGF-1 axis. This is the adaptive baseline against which the other three patterns read. Record the ratio and the paired absolute values as the longitudinal anchor.
Pattern 2 — Low-bracket IGF-1, mid-or-upper-bracket IGFBP-3, ratio below 10. The LEA signature. The IGF-1 may still report "within reference" on the laboratory read, but the molar discordance against the slower-falling IGFBP-3 pool flags the specific hepatic GH-resistance pattern that documents the LEA physiology before the clinical RED-S diagnosis consolidates against the menstrual, bone-density, and metabolic-rate arms. Paired with a low free T3, a luteal-phase deficiency or secondary amenorrhea, a DXA bone-mineral-density trajectory loss, or a resting metabolic rate running 10 percent or more below the Harris-Benedict or Cunningham prediction, this is the biochemical fingerprint of the under-fueled athlete.
Pattern 3 — Upper-bracket IGF-1, upper-bracket IGFBP-3, ratio above 20. The elevated-GH-signal pattern. Differential: adolescent growth spurt (expected and transient in the 14-to-18 year-old presentation), exogenous GH or IGF-1 use (the WADA-prohibited-list differential in the professional or elite-amateur athlete), acromegaly (the rare pituitary adenoma differential), and insulin-resistance-driven IGFBP-3 displacement (in the masters-athlete metabolic-syndrome differential). The sports RD flags the pattern against the age-and-career-stage context and escalates to sports-endocrinology for the stimulation-testing and pituitary-imaging workup when the growth-spurt context is not applicable.
Pattern 4 — Low-bracket IGF-1, low-bracket IGFBP-3, ratio inside 10–16. The pan-hepatic suppression pattern. Both markers fall together, the ratio reads in the balanced band, but the absolute pool is depleted. Differential: hypopituitarism with growth-hormone deficiency, severe chronic illness, protein-calorie malnutrition at the GLIM-criteria severity threshold, cirrhosis or other advanced hepatic dysfunction. The sports RD escalates to sports-endocrinology regardless of the apparently balanced ratio; the ratio reading is not reassuring when both arms are compressed.
The Four Presentations That Earn the Ordered Draw
Presentation 1 — Female athlete with LEA pattern plus menstrual disruption plus performance regression. An estimated energy availability below 30 kcal per kilogram fat-free mass per day, a self-reported oligomenorrhea or secondary amenorrhea, and a four-week-plus plateau or regression on sport-specific performance markers. The paired IGF-1/IGFBP-3 draw reads the hepatic GH-IGF-1 axis against the RED-S differential and anchors the intervention trajectory against the molar-ratio redraw at eight to twelve weeks.
Presentation 2 — Male athlete with the REDS-male differential. A self-reported loss of morning-erection frequency, a loss of libido, a stress-fracture history, or a DXA bone-mineral-density trajectory loss on a male athlete with an endurance- or weight-class-sport training profile. The REDS-male literature — Fredericson, Mountjoy, and the 2023 IOC consensus update — reads the IGF-1/IGFBP-3 molar ratio against the paired testosterone-SHBG-free-T pattern and the paired free-T3-cortisol-DHEA-S read.
Presentation 3 — Masters athlete with unexplained fatigue plus fat-free-mass loss against stable training. A loss of DXA-measured fat-free mass of one kilogram or more across a 16-week window with an unchanged training stimulus and a reported intake that reads adequate on the recall log. The paired draw separates the age-related IGF-1 decline that reads inside the age-decade bracket (Pattern 1) from the pan-suppression pattern that reads below bracket for both markers (Pattern 4) and earns the sports-endocrinology referral.
Presentation 4 — Return-to-training after a prolonged under-fueled layoff or forced injury rest. An athlete returning from a four-week-plus layoff that carried an under-fueled or hospitalized presentation requires a baseline paired IGF-1/IGFBP-3 against the age-decade reference bracket to anchor the return-to-training-load ramp and the intake-target prescription. A Pattern 2 molar discordance at return-to-training reads the hepatic GH-resistance signature as still-active and structures a slower ramp with an explicit eight-week redraw before the full-training load is re-authorized.
Draw Timing, Specimen Handling, and the Paired Panel
Both IGF-1 and IGFBP-3 are drawn as serum on a standard red-top or serum-separator tube. No fasting is required. No timed-draw protocol is required because the ternary-complex biology makes both pools stable across the day; a morning draw between 7 and 9 a.m. local is the practical scheduling default to coordinate with the paired panel.
The paired panel the sports RD orders alongside the IGF-1/IGFBP-3 draw: free T3, free T4, TSH (the thyroid arm of the RED-S differential), LH, FSH, estradiol in the female athlete (the hypothalamic-pituitary-gonadal arm), total testosterone, SHBG, and free-testosterone calculation in the male athlete, prolactin (the pituitary-screen marker that rules in or out the prolactinoma differential before Pattern 3 is interpreted), morning serum cortisol and DHEA-S with the computed cortisol-to-DHEA-S ratio (the HPA-axis arm), fasting glucose and fasting insulin (the fuel-availability arm), a complete blood count, ferritin, and 25-hydroxyvitamin D. The paired panel reads the GH-IGF-1 axis against every adjacent axis that contributes to the RED-S or overtraining differential in a single draw.
Schedule the draw on the first morning of a rest or light-session day, 24 hours clear of the last hard training session. The free-T3 and the morning cortisol are both sensitive to the previous 24-hour training-load exposure, and the paired-panel interpretation is cleaner against a 24-hour recovery window. Record the assay methodology (immunochemiluminescence vs mass spectrometry) for both IGF-1 and IGFBP-3 in the Objective section; the laboratory-to-laboratory variance at the top and bottom of each reference bracket is clinically meaningful and the follow-on redraw must come from the same laboratory using the same assay to keep the trajectory interpretable.
The SOAP Structure
Subjective. Document the presenting complaint (plateau, performance regression, body-composition drift, menstrual disruption, stress-fracture history, REDS-male symptom complex), the training-load trajectory across the preceding mesocycle, the dietary-intake trajectory with an explicit energy availability estimate in kilocalories per kilogram fat-free mass per day, any wearable-data signals (resting heart rate drift, HRV drift, sleep-efficiency drift), any cycle-tracking data, any DXA or bone-density trajectory, any concurrent hormonal contraception, and any concurrent medications (glucocorticoids, estrogens, insulin-sensitizing agents).
Objective. Record the paired IGF-1 and IGFBP-3 values, the age-decade reference brackets, the percent-of-bracket-midpoint for each, and the computed molar ratio against the balanced-axis band. Record the full paired-panel values. Record the pattern classification (1, 2, 3, or 4) from the paired-draw interpretation. Record the DXA or bone-turnover-marker trajectory if available. Record the laboratory assay methodology so the follow-on redraw matches.
Assessment. Read the paired pattern against the clinical differential. Document the ruled-out differentials with reference to the paired markers that ruled them out — hypothyroidism ruled in or out by free T3 and TSH, iron-driven fatigue ruled in or out by CBC and ferritin, HPA-axis overtraining ruled in or out by the cortisol-to-DHEA-S ratio, hypogonadism ruled in or out by LH, FSH, and the gonadal steroid pattern, prolactinoma ruled in or out by paired prolactin. Name the pattern explicitly and tie it to the RED-S or GH-deficiency differential by mechanism, not by exclusion alone.
Plan. Write the energy-availability intervention: a carbohydrate-availability floor against the training-load calendar, a protein-distribution target against the fat-free-mass preservation goal, and a total-intake target against the computed EA floor of 45 kcal per kilogram fat-free mass per day. Write the training-load coordination with the strength-and-conditioning coach where the bone-density-at-risk pattern earns a reduction in high-impact loading and the fat-free-mass-preservation pattern earns a redistribution toward resistance loading. Write the sports-endocrinology referral trigger (Pattern 3 elevated ratio paired with a non-growth-spurt age context, Pattern 4 pan-suppressed at any age, any molar ratio outside the 6-to-20 band paired with a secondary endocrine-axis abnormality). Schedule the follow-on redraw at eight to twelve weeks post-intervention.
Referral Pathways and Follow-On Redraw Cadence
A Pattern 2 molar discordance below 8 paired with a DXA bone-mineral-density trajectory loss and an anovulatory cycle pattern earns the sports-endocrinology referral for the RED-S care-team coordination against the full multidisciplinary workup. A Pattern 3 elevated ratio in a masters or professional athlete with a non-applicable growth-spurt context earns the WADA-aware referral for the doping differential or the acromegaly workup — paired growth-hormone stimulation testing, an OGTT-with-GH-suppression test, and a pituitary MRI in the stimulation-test-positive athlete. A Pattern 4 pan-suppression pattern earns the pituitary workup with the insulin-tolerance test or the glucagon-stimulation test against the growth-hormone-deficiency differential and the paired cortisol axis read against the panhypopituitarism differential.
The follow-on redraw cadence is eight to twelve weeks post-intervention. The eight-week window captures the hepatic GH-resistance reversal timeline in the responding athlete — three to four IGF-1 half-lives for the hepatic-synthesis axis to re-equilibrate against the corrected caloric input. A responsive athlete shows an IGF-1 drift toward the bracket midpoint and a molar ratio normalization back into the 10-to-16 band. A non-responding athlete with a persistent molar discordance despite documented EA intervention earns the escalation referral regardless of the apparent intake-trajectory change; the biochemistry reads a continuing hepatic GH-resistance signature the self-reported intake does not capture, and the sports-endocrinology team carries the next step.
Where Calsanova Fits
Calsanova's clinical intake carries the energy-availability capture that anchors the LEA differential against the training-load-and-wearable-data capture, the menstrual-cycle and REDS-male symptom-complex capture that flags the paired-draw presentation, the paired lab-interpretation module that pre-computes the IGF-1/IGFBP-3 molar ratio against the age-decade reference brackets with the pattern classification pre-computed from the paired-panel entries, the paired-panel template that assembles the RED-S or overtraining differential (free T3, LH/FSH, gonadal steroids, prolactin, cortisol-to-DHEA-S ratio, fasting glucose and insulin, CBC, ferritin, 25-OH-D) in one view, the SOAP template pre-populated against the pattern-specific interpretation with the EA-intervention, training-load-coordination, and referral branches of the plan assembled from the pattern-specific template library, the assay-methodology field that carries forward to the follow-on redraw order so the trajectory stays interpretable, and the follow-on-redraw scheduler that places the eight-to-twelve-week recheck on the athlete's calendar at the moment of the intervention.
Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the paired IGF-1/IGFBP-3 workup runs cleanly against the age-decade reference brackets, the four-pattern paired interpretation, the paired RED-S panel, the SOAP template, and the eight-to-twelve-week follow-on redraw scheduler that tracks the recovery trajectory against the dietary, training-load, and sports-endocrinology-referral branches of the plan.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
1,25-Dihydroxyvitamin D vs 25-Hydroxyvitamin D in the Athlete Clinical Workup: Why the Active-Form Assay Reads the Calcium-Demand-Driven Up-Regulation the Storage-Form Trajectory Does Not See, the Four Paired-Draw Patterns That Classify the Vitamin D Endocrine Axis, the Four Athlete-Population Presentations That Earn the Ordered Paired Draw, and the SOAP Structure That Carries the Finding Into the Dietary, Bone-Health, and Sports-Endocrinology-Referral Branches of the Plan
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log at 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical. The storage-form vitamin D reads replete against both the Endocrine Society and Institute of Medicine reference brackets. The clinician reads the panel as vitamin D sufficient. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log tell the sports RD the vitamin D endocrine axis is not readable from the 25-OH-D alone. The marker that reads the calcium-demand-driven activation of the renal 1-alpha-hydroxylase — 1,25-dihydroxyvitamin D, calcitriol, the active hormonal form — is the one the sports RD pairs with the storage marker on the next draw. This is the paired 25-OH-D plus 1,25-DH-D interpretation guide for the sports RD: the storage-vs-hormone biology that drives the dissociated read, the Endocrine Society and active-form reference brackets, the four paired-draw patterns that classify the vitamin D endocrine axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the calcium-phosphate-PTH-FGF-23 axis, the SOAP structure that carries the finding into the dietary, bone-health, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 17, 2026
DHEA-S in the Athlete Clinical Workup: Why the Long-Half-Life Adrenal Androgen Reads the Integrated HPA-Axis Burden That the Spot Cortisol Does Not See, the Cortisol-to-DHEA-S Ratio That Separates Functional Overreaching From Non-Functional Overtraining, the Four Athlete-Population Presentations That Earn the Ordered Draw, and the SOAP Structure That Carries the Finding Into the Training-Load, Recovery-Window, and Sports-Endocrinology-Referral Branches of the Plan
A 24-year-old male collegiate 1500-meter runner presents at week 14 of a 20-week championship build with a six-week plateau on his 800-meter repeat splits, a resting heart rate drift of 8 bpm above his 14-day baseline on a Whoop morning read, a sleep-efficiency drift from 91 to 83 percent, a Profile-of-Mood-States score inside the elevated-fatigue bracket, and a morning salivary cortisol the sports-medicine physician drew two weeks earlier that returned 14.2 nmol/L — inside the laboratory reference bracket. The spot cortisol reads the panel as normal. The integrated HPA-axis burden that is actually driving the plateau is not readable on the spot cortisol. The marker that reads the eight-to-ten-hour integrated adrenal pool — dehydroepiandrosterone sulfate, the long-half-life adrenal androgen — is the one the sports RD has to add to the next panel. This is the DHEA-S interpretation guide for the sports RD: the zona-reticularis biology that drives the stable-pool read, the reference bracket by sex and age decade, the cortisol-to-DHEA-S ratio that separates adaptive HPA drive from maladaptive HPA suppression, the four athlete-population presentations that earn the ordered draw, the SOAP structure that carries the finding into the training-load, recovery-window, and sports-endocrinology-referral branches of the plan, and the six-to-eight-week follow-on redraw cadence that tracks the recovery trajectory against the taper or deload prescription.
November 12, 2026
Prealbumin (Transthyretin) in the Under-Fueled Athlete Workup: Why Albumin Is the Wrong Marker for the Acute Energy-Availability Transition, the 48-Hour Half-Life Signal That Catches the Fuel Deficit Before Weight Changes, the Paired Prealbumin-CRP-Ferritin Read That Rules In vs. Rules Out, and the SOAP Structure That Carries the Marker Into the Low-Energy-Availability Documentation Chain
A 19-year-old female collegiate rower reports to the sports RD mid-season after a strength coach flagged a 500-meter erg test regression and three weeks of flat afternoon sessions. Weight is within 1.2 kg of her season-opening baseline. Albumin returned at 4.1 g/dL, well inside reference, and the primary care note read 'nutritional status normal.' The read misses the question the presentation is actually asking: has the athlete's protein-synthesis balance shifted in the last 10 to 14 days in a way the long-half-life markers cannot see yet. Albumin's 20-day half-life makes it the wrong instrument for the acute under-fueling window. Prealbumin (transthyretin), with a half-life of roughly 48 hours and a tight response to visceral protein-synthesis balance, is the lab marker that catches the energy-availability transition before weight, albumin, or clinical presentation move. This is the prealbumin interpretation guide for the sports RD: what prealbumin actually measures and why its 48-hour half-life makes it the acute-fueling-status instrument albumin is not, why the CRP paired read is non-negotiable (prealbumin is a negative acute-phase reactant and suppresses with inflammation independent of nutrition), the paired prealbumin-CRP-ferritin interpretive framework that separates true under-fueling from inflammation-driven suppression from compound presentations, the four intake presentations that should trigger the workup regardless of a within-reference albumin or stable body weight, and the SOAP documentation structure that carries the paired-marker read into the low-energy-availability flag before body weight and clinical performance regress far enough to drive the obvious diagnosis.
October 1, 2026